Imlunestrant, An Oral Selective Estrogen Receptor Degrader, In Combination With Abemaciclib With Or Without An Aromatase Inhibitor, In Estrogen Receptor-Positive Advanced Breast Cancer: Results From The Phase 1A/B Ember Study
Abemaciclib;Imlunestrant
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Imlunestrant, An Oral Selective Estrogen Receptor Degrader, In Combination With Abemaciclib With Or Without An Aromatase Inhibitor, In Estrogen Receptor-Positive Advanced Breast Cancer: Results From The Phase 1A/B Ember Study ### Output: Abemaciclib;Imlunestrant